Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Arcadia Biosciences Q1 2024 GAAP EPS $(1.78) Beats $(2.52) Estimate, Sales $1.255M Beat $1.194M Estimate

Author: Benzinga Newsdesk | May 09, 2024 04:56pm

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(1.78) per share which beat the analyst consensus estimate of $(2.52) by 29.37 percent. This is a 83.61 percent increase over losses of $(10.86) per share from the same period last year. The company reported quarterly sales of $1.255 million which beat the analyst consensus estimate of $1.194 million by 5.15 percent. This is a 1.87 percent increase over sales of $1.232 million the same period last year.

Posted In: RKDA